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Two novel isomeric tetraoxygenated homoisoflavanones, 6-hydroxy-7 -O-methyl-3-(3-hydroxy-4-0-
methylbenzyl) chroman-4-one 1 and 6-hydroxy-7-0-methyl-3-( 4-hydroxy-3-0-methylbenzyl) chroman-
4-one 2 have been synthesised and the structure of a new homoisoflavanone, reported from Pterocarpus
marsupium Roxb, has been confmned as 1 by direct comparison with synthetic samples.
A new homoisoflavanone (pteromarsupone) has (4-0-acetyl-3-0-methylbenzylidene) chroman-4-
been recently isolated by Jain et al. I from Ptero- one 8 and 6-0-acetyl-7 -O-methyl-3-(3-0-acetyl-4-
carpus marsupium Roxb. Its structure was pro- O-methylbenzylidene) chroman-4-one 11 respec-
posed as 6-hydroxy-7-0-methyl-3-(3-hydroxy-4- tively. Saponification of 8 and 11 separately, fol-
O-methylbenzyl) chroman-4-one 1 based on spec- lowed by hydrogenation using calculated amount
tral- data. However, there was some ambiguity of H/Pd-C in ethyl acetate afforded 6-hydroxy-7-
about the positions of methoxy and hydroxy O-methyl-3-(4-hydroxy-3-0-methylbenzyl) chro-
groups in the benzyl moiety. The NMR of 1 indi- man-4-one 2 and 6-hydroxy-7-0-methyl-3-(3-
cated the presence of 3,4-dioxygenation pattern" hydroxy-4-0-methylbenzyl) chroman-4-one 1 re-
The methoxy group was fixed at C-4 on the basis spectively. On direct comparison, the natural sam-
of NOE studies and consequently the hydroxy ple of pteromarsupone was found to be different
group was placed at C-3. Since there was no direct from 6-hydroxy-7 -O-methyI-3-( 4-hydroxy-3-0-
proof for such assignments, therefore it became methylbenzyI) chroman-4-one 2 but identical (Co-
necessary to synthesise both the possible isomeric TLC, Co-IR and mmp) with the synthetic sample
homoisoflavanones 1 and 2 in order to confirm the of 6-hydroxy-7 -O-methyl-3-(3-hydroxy-4-0-
assigned constitution by direct comparison. Further methylbenzyl) chroman-4-one 1. Also the IH NMR
literature survey revealed that homoisoflavanone and 13CNMR spectras and the mass spectral frag-
bearing 6,7,3',4'-tetraoxygenation pattern is novel mentation patterns agreed well for both the syn-
and not known. Some of the naturally occurring thetic and natural samples, thereby confirming the
homoisoflavanones are found to possess antibacte- assigned constitution. This is the first report on the
rial:', antimutagenic" and antiinflamatory'" activi- synthesis of 6,7,3',4'-tetraoxygenated homoiso-
ties and are of chemotaxonomic" interests also. In flavanones in literature.
view of these facts, we undertook the synthesis of
1 and its isomer 6-hydroxy-7-0-methyl-3-(4- Experimental Section
hydroxy-3-0-methylbenzyl) chroman-4-one 2 General. All melting points are uncorrected and
starting from the intermediate 6-hydroxy-7-0- were determined in a sulphuric acid bath. UV
methyl chroman-4-one 5, prepared from 4 by hy- spectra were recorded on Beckman DU-64 spec-
drogenation. 4 in turn was obtained by reacting 5- trophotometer in methanol, IR spectra on Shi-
O-benzyl- 2-hydroxy-4-0-methyl acetophenone" 3 madzu model-435 spectrophotometer, IH NMR
and ethyl formate in presence of pulvarized so- spectra on either Brucker or Perkin-Elmer model
dium. The chromanone 5 on condensation sepa- (300 MHz) (250 MHz), (90 MHz) and (60 MHz)
rately with vanillin 7 and isovanillin 10 in boiling and 13CNMR on Brucker (62.89 or 75.42 MHz)
acetic anhydride gave 6-0-acetyl-7-0-methyl-3- using TMS as internal standard. Chemical shifts

























a= HCOOEVNa; b= HiPd-C/EtOAc; c= Anhydrous Ac,O. d= NaOHI MeOH
were quoted in 0 ppm and J values in Hz. Mass
spectra were recorded on a Varian MAT 311A in-
strument. Silica gel 60-120 mesh was used for col-
umn chromatography and TLC was performed us-
ing silica gel G.
6-0-Benzyl-7-0-methylchromone 4. A solution
of 5-0-benzyl-2-hydroxy-4-0-methyl acetophe-
none" 3 (5.5 g, 19.0 mmol) in dry ethyl formate
(120 mL) was added to pulvarized sodium (6.4 g,
278.0 mmol) under dry conditions and the contents
stirred for 24 hr. The resulting reaction mixture
was then decomposed with ice cold 10% HCl and
the ethyl formate from the mixture was evaporated
on the steam bath. The oily residue was left, which
on cooling gave 6-0-benzyl-7-0-methy1chromone
4 as a solid. It was filtered and crystallised from
chloroform-petrol as colourless crystals, yield 2.82
g, m.p. 129°, RFO.l8 (benzene/ethyl acetate, 95:5).
IR(KEr): 3020, 1650, 1625, 1605, 1510, 1480,
1455, 1400, 1305, 1270, 1245, 1230, 1180, 1050,
970, 865, 815, 755, 700; IH NMR (CDCI3): 3.96 (s,
3H, OCH3), 5.20 (s, 2H, -CH2-C6Hs), 6.29 (d, J=6
Hz, IH, H-3), 6.87 (s, IH, H-8), 7.42 (m, 5H, -
C6HS)' 7.62 (s, IH, H-5), 7.80 (d, J=6 Hz, H-2); 13C
NMR(CDC13): 176.81, 154.98, 154.51, 152.76,
146.76, 136.09, 128.61, 128.15, 127.61, 118.16,
112.39, 106.14,99.83, 70.95, 58.36, 56.35.
6-Hydroxy-7-0-methylchroman-4-one 5. A so-
lution of 4 (4.0 g, 14.0 mmol) in dry ethyl acetate
(50 mL) and palladized charcoal (12.0 g, 10%) was
stirred in the atmosphere of hydrogen at rt for 30
min. Absorption of hydrogen was rapid in the be-
ginning but stopped completely at the end of this
period. The catalyst was filtered and washed with
ethyl acetate. The solvent was removed from the
combined filtrate under reduced pressure when 5
along with small amount of 6-hydroxy- 7-0-
methy1chromone 6 was obtained. The separation of
these compounds was carried out by column chro-
matography using silica gel as an adsorbent. Elu-
tion of the column with benzene : ethyl acetate
(98:2) and (95:5) afforded compound 5 (major)
and 6 (minor) respectively.
Compound 5 was crystallised from chloroform-
petrol as colourless solid, yield 1.59 g, m.p. 14r,
R, 0.46 (benzene: ethyl acetate, 95:5) (Found: C,
61.l5; H, 5.11 CloHI004 requires C, 61.85; H,
5.15%); IR (KEr): 3000, 2960, 1628, 1550, 1520,
1480, 1450, 1418, 1280, 1180, 1020, 980, 936,
860, 810, 740 ern"; IH NMR (CDCI3): 2.73 (t, 2H,
H-3), 3.91 (s, 3H, OCH3), 4.48 (t, 2H, H-2), 6.42(s,
IH, H-8), 7.37 (s, IH, H-5); 13C NMR(CDCI3):
190.78, 157.59, 153.61, 140.69, 114.47, 110.47,
99.38,67.45,56.16,37.36.
Compound 6 was also crystallised from chi oro-
form-petrol as colourless needles, yield 0.198 g,
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m.p. 208°, R, 0.24 (benzene: ethyl acetate, 95:5)
(Found: C, 62.43; H, 4.19. C1JiS04 requires C,
62.50; H, 4.17%); IH NMR(DMSO-d6): 3.90 (s,
3H, OCH3), 6.11 (d, J= 6Hz, 1H, H-3), 6.80 (s, 1H,
H-8), 7.20 (s, 1H, H-5), 8.0 (d, J=6 Hz, 1H, H-2).
6-0-Acetyl-7-0-methyl-3- (4-0-acetyl-3-0-me-
thylbenzylidene) chroman-4-one 8. A mixture of
5 (1.0 g, 5.2 mmol) and vanillin 7 (1g, 6.6 mmol)
in dry acetic anhydride (15 mL) was refluxed for
80 hr. The contents were cooled and diluted with
excess of water. The solid that separated was fil-
tered, washed with water and crystallised from
chloroform-petrol as light yellow solid, yield 1.02
g, m.p. 185°, R, 0.41 (benzene: ethyl acetate,
90: 10). IH NMR (CDCI3): 2.31 and 2.34 (2s, 6H,
2xCOCH3), 3.86 (s, 6H, 2x-OCH3) 5.34 (d, J=1.8
Hz, 2H, H-2), 6.48 (s, 1H, H-8), 6.85 (d, Jo=9 Hz,
IH, H-5'), 7.11 (m, 2H, H-2' and H-6'), 7.67 (s, 1H,
H-5), 7.79 (s, IH, H-9); l3C NMR(CDCI3): 180.10,
169.21, 161.35, 136.30, 122.99, 122.12, 121.15,
113.88, 100.62, 67.84, 56.21, 55.89, 20.57, 20.41;
ElMS mlz 413 (M++1), 412(M+), 371, 370, 330,
329, 328, 327, 194, 168, 167, 165, 163, 162, 161,
147,123,91,83,69,59,43.
6-Hydroxy-7-0-methyl-3- (4-hydroxy-3-0-me-
thylbenzylidene) chroman-4-one 9. Compound 8
(0.5 g, 1.2 mmol) was treated with methanolic
NaOH (2.5 mL, 10%) and contents refluxed with
stirring for an hour. The solvent was then removed
under reduced pressure and water added. The re-
sulting solution was neutralised by dilute HCI and
contents extracted with ether. The ether solution
was dried over anhyd. magnesium sulphate and
inorganic salt filtered. The solvent was distilled off
from the filtrate and the residue thus left was
crystallised from ethanol to give 9 as yellow solid,
yield 0.3 g, m.p. 209°, R, 0.2 (benzene: ethyl ace-
tate, 90: 10). IH NMR(CDCI3): 3.93 and 3.94 (2s,
6H, 2xOCH3), 5.34 (d, J=1.8 Hz, H-2), 6.45 (s, 1H,
H-8), 6.80 (d, Jo=9 Hz, 1H, H-5'), 6.96 (d, Jo=9 Hz,
2H, H-2' and H-6'), 7.51 (s, 1H, H-5), 7.80 (s, 1H,
H-9); ElMS mlz: 329 (M++1), 328 (M+), 297, 168,
167, 166, 163, 162, 148, 147, 123, 119,99, 77, 69,
65.
6-Hydroxy-7-0-methyl-3- (4-hydroxy-3-0-me-
thylbenzyl) chroman-4-one 2. To a solution of 9
(0.2 g, 0.06 mmol) in dry ethyl acetate (5 mL),
palladized charcoal (0.5 g, 10%) was added and
contents stirred in atmosphere of hydrogen at rt.
The progress of reaction was monitored on TLC.
Examination of TLC after 40 min. showed the ab-
sence of compound 9 and the presence of a new
compound at higher R, The reaction was worked
up as usual. The residue left was crystallised to
give 2 as colourless solid, yield 0.12 g, m.p 195°,
R, 0.44 (benzene: ethyl acetate, 90: 10). IH NMR
(DMSO-d6): 2.49 and 2.93 (2dd, 1H each, H-9),
2.69 (m, 1H, H-3), 3.68 and 3.75 (s, 6H, 2xOCH3),
4.14 (dd, J = 1.8 Hz, 2H, H-2), 6.39 (s, 1H, H-8),
6.69 (dd, Jrn=1.8 Hz and Jo=8.5 Hz, 1H, H-6'), 6.76
(d, i; = 1.8 Hz, 1H, H-2'), 6.80 (d, r, = 8.5 Hz, 1H,
H-5'), 7.40 (s, 1H, H-5); ElMS mlz: 33'0(M+), 313,
194,167,149,138,122,94,72,55,28.
6-0-Acetyl-7-0-methyl-3- (3-0-acetyl-4-0-me-
thylbenzylidene) chroman-4-one 11. A mixture
of 5 (1.0 g, 5.2 mmol) and isovanillin 10 (1g, 6.6
mmol) in the acetic anhydride (15 mL) was re-
fluxed for 80 hr. The contents were cooled and
reaction was worked up as in the synthesis of 8
earlier. The residue left was crystallised from chlo-
roform-petrol to give 11 as light yellow solid, yield
1.01 g, m.p. 173-74°, RFO.38 (benzene: ethyl ace-
tate, 90: 10). IH NMR(CDCI3): 2.20 and 2.25 (2s,
6H, 2xCOCH3), 3.80 (s, 6H, 2xOCH]), 5.32 (s, 2H,
H-2), 6.50 (s, 1H, H-8), 6,92 (d, Jo=9 Hz, 1H, H-
5'),7.18 (m, 2H, H-2' and H-6'), 7.71 (s, 1H, H-5),
7.81(s, 1H, H-9); ElMS mlz: 412(M+), 397, 370,
329,328, 194, 167, 162, 147, 123,91,63,43.
6-Hydroxy-7-0-methyl-3- (3-hydroxy-4-0-me-
thylbenzylidene) chroman-4-one 12 . Compound
11 (0.5 g, 1.2 mmol) was treated with methanolic
NaOH (2.5 mL, 10%) and contents refluxed with
stirring for an hour. The solvent was removed un-
der reduced pressure and water added. The reac-
tion mixture was worked up as described earlier in
the synthesis of 9. The residue obtained was puri-
fied by column chromatography. Elution with ben-
zene/ethyl acetate (90: 10) gave yellow mass con-
taining 12 only which could not be crystallised,
yield 0.90 g. R, 0.18 (benzene: ethyl acetate,
90:10); IH NMR (CD3COCD3): 3.90 (s, 6H,
2xOCH3), 5.43 (s, 2H, H-2), 6.50 (s, 1H, H-8),
6.30 (d, Jo=9 Hz, 1H, H-5'), 7.12 (m, 2H, H-2' and
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H-6'), 7.44 (s, 1H, H-5), 7.80 (s, 1H, H-9); ElMS
mlz: 328(M+), 313, 298, 297, 167, 162, 147, 123,
119, 102,91,69,65.
6-Hydroxy-7-0-methyl-3- (3-hydroxy-4-0-me-
thylbenzyl) chroman-4-one 1. To a solution of 12
(0.15 g, 0.40 mmol) in ethyl acetate (5 mL), pal-
ladized charcoal (0.4 g, 10%) was added and con-
tents stirred in the atmosphere of hydrogen at rt.
The progress of reaction mixture was monitored by
TLC and the reaction mixture was worked up as
usual when it showed the presence of a new com-
pound at a higher R, value. The crude residue thus
obtained was purified by column chromatography 2
to yield 1 as dirty white solid. It was crystallised
from chloroform-methanol as colourless needles, 3
yield 0.10 g, m.p. 186-87°, UV(CH30H): 276 nm; 4
IR (KBr): 3400, 1640 cm'; IH NMR(CD3COCD3): 5
2.6 and 3.1 (2dd, IH each, H-9), 2.8 (m, 1H, H-3),
3.8 (s, 6H, 2xOCH3), 4.1 and 4.4 (2dd, 1H each, H- 6
2), 6.5 (s, 1H, H-8), 6.7 (dd, J=1.8 and 8.1 Hz, IH,
7H-6'), 6.7 (d, Jm=1.8 Hz, 1H, H-2'), 6.8 (d, Jo=8.1
Hz, IH, II-5'),' 7.2 (s, 1H, H-5); 13C 8
NMR(CD3COCD3): 191.8, 157.2, 152.2, 146.3,
132.0, 120.2, 116.1, 116.0, 112.0, 110.5, 100.0,
70.2, 55.9, 55.7, 47.4, 31.8; ElMS mlz: 330(M+),
313, 194, 193, 167, 149, 138, 137, 122,94, 72, 55,
28.
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